Table 5.
Results of selected parameters before and after cART in HIV-infected men by HIV RNA viral load (below and above 100,000 copies/mL) with statistical analysis.
| HIV RNA ≤ 100,000 [Copies/mL] (N = 31) |
HIV RNA > 100,000 [Copies/mL] (N = 22) |
p * | |
|---|---|---|---|
| Me (IQR) | Me (IQR) | ||
| HIV-Infected Men before cART (A) | |||
|
IRS
[ng/mL] |
5.15 (1.60–21.80) | 4.10 (1.80–18.10) | 0.24 |
|
MSTN
[ng/mL] |
261.60 (83.20–707.60) | 128.75 (72.90–445.50) | 0.36 |
|
PYY
[pg/mL] |
192.05 (125.85–313.85) | 149.35 (126.90–255.60) | 0.87 |
|
GLP-1
[ng/mL] |
243.95 (94.15–684.85) | 103.20 (79.40–369.90) | 0.89 |
|
DPP-4
[ng/mL] |
276.45 (183.00–460.05) | 229.30 (179.70–281.30) | 0.47 |
|
FETU-A
[ng/mL] |
287.95 (133.30–1437.00) | 156.00 (121.50–458.30) | 0.56 |
|
PTX3
[ng/mL] |
3.00 (1.10–8.45) | 2.40 (0.90–4.20) | 0.57 |
|
SDF-1
[ng/mL] |
2.00 (0.70–8.65) | 0.90 (0.70–2.80) | 0.50 |
|
RANTES
[ng/mL] |
386.45 (117.50–992.45) | 207.80 (88.45–608.55) | 0.72 |
Abbreviation: A—HIV-infected man before cART; B—HIV-infected man after cART; Me—median; IQR—interquartile range; N—number of participants; IRS—irisin; MSTN—myostatin; PYY—peptide YY; GLP-1—glucagon-like peptide-1; DPP-4—dipeptidyl peptidase IV; FETU-A—fetuin A; PTX3—pentraxin 3, SDF-1—chemokine stromal cell-derived factor 1; and RANTES—regulated on activation, normal T cell expressed and secreted. * p—statistical significance by U Mann–Whitney test.